Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FiPAKI Pilot Trial: Finerenone in Acute Kidney Injury
NCT07775482Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute kidney injury (AKI) comparing Finerenone with Placebo (2 arms). Primary endpoints: Recruitment success at 2 years, Adherence to study drug at Day 45 and 1 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07775482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775482.